Trial Profile
Bisoprolol fumarate; for prevention of atrial fibrillation after coronary artery bypass grafting: randomized, prospective, open-label study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2017
Price :
$35
*
At a glance
- Drugs Bisoprolol (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 16 Jun 2017 Status changed from recruiting to discontinued.
- 25 Jun 2013 New trial record